E-LIB Suche - Ergebnisse für: Hofmann, Carsten

1

Enabling Subcutaneous Dosing of Gantenerumab in Alzheimer's..:

Bittner, Beate ; Schwab, Dietmar ; Portron, Agnes...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

2

Delivery of the Brainshuttle™ amyloid-beta antibody fusion ..:

Grimm, Hans Peter ; Schumacher, Vanessa ; Schäfer, Martin...
mAbs. 15 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

3

Das "Schriftform"-Erfordernis (§ 183 Abs. 1 lit. c) CRR) al..:

, In: Wertpapier-Mitteilungen

Hofmann, Carsten ; Chionos, Tatjana. (2022) 28 - p. 1362-1365

Copies: Juridicum: z jur 825/680

4

Impact of model misspecification on model-based tests in PK..:

Guhl, Mélanie ; Mercier, François ; Hofmann, Carsten...
Journal of Pharmacokinetics and Pharmacodynamics. 49 (2022) 5 - p. 557-577 , 2022

Link: https://doi.org/10.1007/..

5

Linking amyloid to clinical outcome: A quantitative semi‐me..:

Mazer, Norman A ; Hofmann, Carsten ; Lott, Dominik...
Alzheimer's & Dementia. 18 (2022) S3 - p. , 2022

Link: https://doi.org/10.1002/..

6

Evaluation of dose‐dependent treatment effects after mid‐tr..:

Wang, Guoqiao ; Li, Yan ; Xiong, Chengjie...
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 14 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

7

Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Tr..:

Joseph‐Mathurin, Nelly ; Llibre‐Guerra, Jorge J. ; Li, Yan...
Annals of Neurology. 92 (2022) 5 - p. 729-744 , 2022

Link: https://doi.org/10.1002/..

8

Quantitative systems pharmacology model of the amyloid path..:

Ramakrishnan, Vidya ; Friedrich, Christina ; Witt, Colleen...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2022) 1 - p. 62-73 , 2022

Link: https://doi.org/10.1002/..

9

Baseline participant characteristics of GRADUATION: a study..:

Boess, Frank ; Lane, Christopher ; Scelsi, Marzia A....
Alzheimer's & Dementia. 18 (2022) S10 - p. , 2022

Link: https://doi.org/10.1002/..

10

Development of a quantitative semi‐mechanistic model of Alz..:

Mazer, Norman A. ; Hofmann, Carsten ; Lott, Dominik...
Alzheimer's & Dementia. 19 (2022) 6 - p. 2287-2297 , 2022

Link: https://doi.org/10.1002/..

11

In silico exploration of amyloid‐related imaging abnormalit..:

Aldea, Roxana ; Grimm, Hans Peter ; Gieschke, Ronald...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1002/..

12

Disease Modeling and Model‐Based Meta‐Analyses to Define a ..:

Retout, Sylvie ; Gieschke, Ronald ; Serafin, Daniel...
Clinical Pharmacology & Therapeutics. 111 (2022) 4 - p. 857-866 , 2022

Link: https://doi.org/10.1002/..

13

Graduation study design: Evaluation of once‐weekly subcutan..:

Boess, Frank ; Sakaoka, Shunsuke ; Abi‐Saab, Danielle...
Alzheimer's & Dementia. 17 (2021) S9 - p. , 2021

Link: https://doi.org/10.1002/..

14

Characterization of amyloid‐related imaging abnormality in ..:

Joseph‐Mathurin, Nelly ; Llibre‐Guerra, Jorge J ; McCullough, Austin A....
Alzheimer's & Dementia. 17 (2021) S1 - p. , 2021

Link: https://doi.org/10.1002/..

15

Linking Amyloid to Cognition in the Pathogenesis and Treatm..:

Mazer, Norman A. ; Hofmann, Carsten ; Lott, Dominik...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..